There’s Still Time to Buy DICE Therapeutics Inc. (NASDAQ:DICE) Stock
In yesterday’s Wall Street session, DICE Therapeutics Inc. (NASDAQ:DICE) shares traded at $47.45, up 0.15% from the previous session. 9 analysts cover DICE Therapeutics Inc. (NASDAQ:DICE), according to research data. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $48.00 and a […]
Do investors have a safe investment in DICE Therapeutics Inc. (NASDAQ:DICE)?
The price of DICE Therapeutics Inc. (NASDAQ:DICE) shares last traded on Wall Street fell -0.45% to $46.50. Based on available information, 10 analysts follow DICE Therapeutics Inc. (NASDAQ:DICE). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $48.00 and a low of […]
